申请人:3M Innovative Properties Company
公开号:US07884207B2
公开(公告)日:2011-02-08
Imidazo-quinoline, -pyridine, and -naphthyridine ring systems (particularly quinolines, tetrahydroquinolines, pyridines, [1,5]naphthyridines, [1,5]tetrahydronaphthyridines) substituted at the 1-position with a cyclic substituent, pharmaceutical compositions containing the compounds, methods of making these compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
本发明涉及在1位被环状取代基取代的咪唑喹啉、吡啶和萘啶环系统(特别是喹啉、四氢喹啉、吡啶、[1,5]萘啶和[1,5]四氢萘啶),以及包含这些化合物的制药组合物,制备这些化合物的方法以及将这些化合物用作免疫调节剂的方法,用于诱导动物中的细胞因子生物合成和治疗包括病毒和肿瘤疾病在内的疾病。